{
    "name": "Schedule I",
    "number": "14",
    "text": "\u00a7329-14\u00a0 Schedule I.\u00a0 (a)\u00a0 The controlled substances listed in this section are included in schedule I.\n\u00a0\u00a0\u00a0\u00a0 (b)\u00a0 Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Acetylmethadol;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Allylprodine;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Alphacetylmethadol (except levo-alphacetylmethadol, levomethadyl acetate, or LAAM);\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Alphameprodine;\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 Alphamethadol;\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);\n\u00a0\u00a0\u00a0\u00a0 (8)\u00a0 Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);\n\u00a0\u00a0\u00a0\u00a0 (9)\u00a0 Benzethidine;\n\u00a0\u00a0\u00a0 (10)\u00a0 Betacetylmethadol;\n\u00a0\u00a0\u00a0 (11)\u00a0 Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);\n\u00a0\u00a0\u00a0 (12)\u00a0 Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);\n\u00a0\u00a0\u00a0 (13)\u00a0 Betameprodine;\n\u00a0\u00a0\u00a0 (14)\u00a0 Betamethadol;\n\u00a0\u00a0\u00a0 (15)\u00a0 Betaprodine;\n\u00a0\u00a0\u00a0 (16)\u00a0 Clonitazene;\n\u00a0\u00a0\u00a0 (17)\u00a0 Dextromoramide;\n\u00a0\u00a0\u00a0 (18)\u00a0 Diampromide;\n\u00a0\u00a0\u00a0 (19)\u00a0 Diethylthiambutene;\n\u00a0\u00a0\u00a0 (20)\u00a0 Difenoxin;\n\u00a0\u00a0\u00a0 (21)\u00a0 Dimenoxadol;\n\u00a0\u00a0\u00a0 (22)\u00a0 Dimepheptanol;\n\u00a0\u00a0\u00a0 (23)\u00a0 Dimethylthiambutene;\n\u00a0\u00a0\u00a0 (24)\u00a0 Dioxaphetyl butyrate;\n\u00a0\u00a0\u00a0 (25)\u00a0 Dipipanone;\n\u00a0\u00a0\u00a0 (26)\u00a0 Ethylmethylthiambutene;\n\u00a0\u00a0\u00a0 (27)\u00a0 Etonitazene;\n\u00a0\u00a0\u00a0 (28)\u00a0 Etoxeridine;\n\u00a0\u00a0\u00a0 (29)\u00a0 Furethidine;\n\u00a0\u00a0\u00a0 (30)\u00a0 Hydroxypethidine;\n\u00a0\u00a0\u00a0 (31)\u00a0 Ketobemidone;\n\u00a0\u00a0\u00a0 (32)\u00a0 Levomoramide;\n\u00a0\u00a0\u00a0 (33)\u00a0 Levophenacylmorphan;\n\u00a0\u00a0\u00a0 (34)\u00a0 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);\n\u00a0\u00a0\u00a0 (35)\u00a0 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);\n\u00a0\u00a0\u00a0 (36)\u00a0 Morpheridine;\n\u00a0\u00a0\u00a0 (37)\u00a0 MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);\n\u00a0\u00a0\u00a0 (38)\u00a0 Noracymethadol;\n\u00a0\u00a0\u00a0 (39)\u00a0 Norlevorphanol;\n\u00a0\u00a0\u00a0 (40)\u00a0 Normethadone;\n\u00a0\u00a0\u00a0 (41)\u00a0 Norpipanone;\n\u00a0\u00a0\u00a0 (42)\u00a0 Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide;\n\u00a0\u00a0\u00a0 (43)\u00a0 PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine;\n\u00a0\u00a0\u00a0 (44)\u00a0 Phenadoxone;\n\u00a0\u00a0\u00a0 (45)\u00a0 Phenampromide;\n\u00a0\u00a0\u00a0 (46)\u00a0 Phenomorphan;\n\u00a0\u00a0\u00a0 (47)\u00a0 Phenoperidine;\n\u00a0\u00a0\u00a0 (48)\u00a0 Piritramide;\n\u00a0\u00a0\u00a0 (49)\u00a0 Proheptazine;\n\u00a0\u00a0\u00a0 (50)\u00a0 Properidine;\n\u00a0\u00a0\u00a0 (51)\u00a0 Propiram;\n\u00a0\u00a0\u00a0 (52)\u00a0 Racemoramide;\n\u00a0\u00a0\u00a0 (53)\u00a0 Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);\n\u00a0\u00a0\u00a0 (54)\u00a0 Tilidine;\n\u00a0\u00a0\u00a0 (55)\u00a0 Trimeperidine;\n\u00a0\u00a0\u00a0 (56)\u00a0 N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts, and salts of isomers;\n\u00a0\u00a0\u00a0 (57)\u00a0 N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), its optical isomers, salts, and salts of isomers; and\n\u00a0\u00a0\u00a0 (58)\u00a0 N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, (acetyl fentanyl) its optical, positional, and geometric isomers, salts, and salts of isomers.\n\u00a0\u00a0\u00a0\u00a0 (c)\u00a0 Any of the following opium derivatives, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Acetorphine;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Acetyldihydrocodeine;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Benzylmorphine;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Codeine methylbromide;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Codeine-N-Oxide;\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 Cyprenorphine;\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 Desomorphine;\n\u00a0\u00a0\u00a0\u00a0 (8)\u00a0 Dihydromorphine;\n\u00a0\u00a0\u00a0\u00a0 (9)\u00a0 Drotebanol;\n\u00a0\u00a0\u00a0 (10)\u00a0 Etorphine;\n\u00a0\u00a0\u00a0 (11)\u00a0 Heroin;\n\u00a0\u00a0\u00a0 (12)\u00a0 Hydromorphinol;\n\u00a0\u00a0\u00a0 (13)\u00a0 Methyldesorphine;\n\u00a0\u00a0\u00a0 (14)\u00a0 Methyldihydromorphine;\n\u00a0\u00a0\u00a0 (15)\u00a0 Morphine methylbromide;\n\u00a0\u00a0\u00a0 (16)\u00a0 Morphine methylsulfonate;\n\u00a0\u00a0\u00a0 (17)\u00a0 Morphine-N-Oxide;\n\u00a0\u00a0\u00a0 (18)\u00a0 Myrophine;\n\u00a0\u00a0\u00a0 (19)\u00a0 Nicocodeine;\n\u00a0\u00a0\u00a0 (20)\u00a0 Nicomorphine;\n\u00a0\u00a0\u00a0 (21)\u00a0 Normorphine;\n\u00a0\u00a0\u00a0 (22)\u00a0 Phoclodine; and\n\u00a0\u00a0\u00a0 (23)\u00a0 Thebacon.\n\u00a0\u00a0\u00a0\u00a0 (d)\u00a0 Any material, compound, mixture, or preparation that contains any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Alpha-ethyltryptamine (AET);\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 2,5-dimethoxy-4-ethylamphetamine (DOET);\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 2,5-dimethoxyamphetamine (2,5-DMA);\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 3,4-methylenedioxy amphetamine;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 3,4-methylenedioxymethamphetamine (MDMA);\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 N-hydroxy-3,4-methylenedioxyamphetamine (N-hydroxy-MDA);\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 3,4-methylenedioxy-N-ethylamphetamine (MDE);\n\u00a0\u00a0\u00a0\u00a0 (8)\u00a0 5-methoxy-3,4-methylenedioxy-amphetamine;\n\u00a0\u00a0\u00a0\u00a0 (9)\u00a0 4-bromo-2,5-dimethoxy-amphetamine (4-bromo-2,5-DMA);\n\u00a0\u00a0\u00a0 (10)\u00a0 4-Bromo-2,5-dimethoxyphenethylamine (Nexus);\n\u00a0\u00a0\u00a0 (11)\u00a0 3,4,5-trimethoxy amphetamine;\n\u00a0\u00a0\u00a0 (12)\u00a0 Bufotenine;\n\u00a0\u00a0\u00a0 (13)\u00a0 4-methoxyamphetamine (PMA);\n\u00a0\u00a0\u00a0 (14)\u00a0 Diethyltryptamine;\n\u00a0\u00a0\u00a0 (15)\u00a0 Dimethyltryptamine;\n\u00a0\u00a0\u00a0 (16)\u00a0 4-methyl-2,5-dimethoxy-amphetamine;\n\u00a0\u00a0\u00a0 (17)\u00a0 Gamma hydroxybutyrate (GHB) (some other names include gamma hydroxybutyric acid; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate);\n\u00a0\u00a0\u00a0 (18)\u00a0 Ibogaine;\n\u00a0\u00a0\u00a0 (19)\u00a0 Lysergic acid diethylamide;\n\u00a0\u00a0\u00a0 (20)\u00a0 Marijuana;\n\u00a0\u00a0\u00a0 (21)\u00a0 Parahexyl;\n\u00a0\u00a0\u00a0 (22)\u00a0 Mescaline;\n\u00a0\u00a0\u00a0 (23)\u00a0 Peyote;\n\u00a0\u00a0\u00a0 (24)\u00a0 N-ethyl-3-piperidyl benzilate;\n\u00a0\u00a0\u00a0 (25)\u00a0 N-methyl-3-piperidyl benzilate;\n\u00a0\u00a0\u00a0 (26)\u00a0 Psilocybin;\n\u00a0\u00a0\u00a0 (27)\u00a0 Psilocyn;\n\u00a0\u00a0\u00a0 (28)\u00a0 1-[1-(2-Thienyl) cyclohexyl] Pyrrolidine (TCPy);\n\u00a0\u00a0\u00a0 (29)\u00a0 Ethylamine analog of phencyclidine (PCE);\n\u00a0\u00a0\u00a0 (30)\u00a0 Pyrrolidine analog of phencyclidine (PCPy, PHP);\n\u00a0\u00a0\u00a0 (31)\u00a0 Thiophene analog of phencyclidine (TPCP; TCP);\n\u00a0\u00a0\u00a0 (32)\u00a0 Gamma-butyrolactone, including butyrolactone; butyrolactone gamma; 4-butyrolactone; 2(3H)-furanone dihydro; dihydro-2(3H)furanone; tetrahydro-2-furanone; 1,2-butanolide; 1,4-butanolide; 4-butanolide; gamma-hydroxybutyric acid lactone; 3-hydroxybutyric acid lactone and 4-hydroxybutanoic acid lactone with Chemical Abstract Service number 96-48-0 when any such substance is intended for human ingestion;\n\u00a0\u00a0\u00a0 (33)\u00a0 1,4 butanediol, including butanediol; butane-1,4-diol; 1,4- butylenes glycol; butylene glycol; 1,4-dihydroxybutane; 1,4- tetramethylene glycol; tetramethylene glycol; tetramethylene 1,4- diol with Chemical Abstract Service number 110-63-4 when any such substance is intended for human ingestion;\n\u00a0\u00a0\u00a0 (34)\u00a0 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its optical isomers, salts, and salts of isomers;\n\u00a0\u00a0\u00a0 (35)\u00a0 N-benzylpiperazine (BZP; 1-benzylpiperazine) its optical isomers, salts, and salts of isomers;\n\u00a0\u00a0\u00a0 (36)\u00a0 1-(3-trifluoromethylphenyl)piperazine (TFMPP), its optical isomers, salts, and salts of isomers;\n\u00a0\u00a0\u00a0 (37)\u00a0 Alpha-methyltryptamine (AMT), its isomers, salts, and salts of isomers;\n\u00a0\u00a0\u00a0 (38)\u00a0 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts, and salts of isomers;\n\u00a0\u00a0\u00a0 (39)\u00a0 Salvia divinorum;\n\u00a0\u00a0\u00a0 (40)\u00a0 Salvinorin A;\n\u00a0\u00a0\u00a0 (41)\u00a0 Divinorin A;\n\u00a0\u00a0\u00a0 (42)\u00a0 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DIPT) (some trade or other names:\u00a0 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT);\n\u00a0\u00a0\u00a0 (43)\u00a0 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);\n\u00a0\u00a0\u00a0 (44)\u00a0 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);\n\u00a0\u00a0\u00a0 (45)\u00a0 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);\n\u00a0\u00a0\u00a0 (46)\u00a0 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);\n\u00a0\u00a0\u00a0 (47)\u00a0 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2);\n\u00a0\u00a0\u00a0 (48)\u00a0 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4);\n\u00a0\u00a0\u00a0 (49)\u00a0 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);\n\u00a0\u00a0\u00a0 (50)\u00a0 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N);\n\u00a0\u00a0\u00a0 (51)\u00a0 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);\n\u00a0\u00a0\u00a0 (52)\u00a0 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5);\n\u00a0\u00a0\u00a0 (53)\u00a0 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82); and\n\u00a0\u00a0\u00a0 (54)\u00a0 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36).\n\u00a0\u00a0\u00a0\u00a0 (e) \u00a0Depressants.\u00a0 Unless specifically excepted, the schedule shall include any material, compound, mixture, or preparation which contains any quantity of the substance:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Mecloqualone; or\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Methaqualone.\n\u00a0\u00a0\u00a0\u00a0 (f)\u00a0 Stimulants.\u00a0 Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Aminorex;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Cathinone;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Fenethylline;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Methcathinone;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 N-ethylamphetamine;\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 4-methylaminorex;\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 N,N-dimethylamphetamine; and\n\u00a0\u00a0\u00a0\u00a0 (8)\u00a0 Substituted cathinones, any compound, except bupropion or compounds listed under a different schedule, structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways:\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (A)\u00a0 By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (B)\u00a0 By substitution at the 3-position with an acyclic alkyl substituent; or\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (C)\u00a0 By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure.\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Some other trade names:\u00a0 Mephedrone (2-methylamino-1-p-tolylpropan-1-one), also known as 4-methylmethcathinone (4-MMC), methylephedrone or MMCAT; Methylenedioxypyrovalerone (MDPV, MDPK); methylone or 3,4-methylenedioxymethcathinone; and 1-(benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)propan-1-one, monohydrochloride, also known as Ethylone, bk-MDEA hydrochloride, MDEC; 3,4-Methylenedioxy-N-ethylcathinone; bk-Methylenedioxyethylamphetamine.\n\u00a0\u00a0\u00a0\u00a0 (g)\u00a0 Any of the following cannabinoids, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Tetrahydrocannabinols; meaning tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following: Delta 1 cis or trans tetrahydrocannabinol, and their optical isomers; Delta 6 cis or trans tetrahydrocannabinol, and their optical isomers; and Delta 3,4 cis or trans-tetrahydrocannabinol, and its optical isomers (since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions, are covered);\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Naphthoylindoles; meaning any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Naphthylmethylindoles; meaning any compound containing a 1H-indol-3-yl-(1-naphthyl) methane structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Naphthoylpyrroles; meaning any compound containing a 3-(1-naphthoyl) pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Naphthylmethylindenes; meaning any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 Phenylacetylindoles; meaning any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent;\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 Cyclohexylphenols; meaning any compound containing a 2-(3-hydroxycyclohexyl) phenol structure with substitution at the 5-position of the phenolic ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not substituted in the cyclohexyl ring to any extent;\n\u00a0\u00a0\u00a0\u00a0 (8)\u00a0 Benzoylindoles; meaning any compound containing a 3-(benzoyl) indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent;\n\u00a0\u00a0\u00a0\u00a0 (9)\u00a0 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone (another trade name is WIN 55,212-2);\n\u00a0\u00a0\u00a0 (10)\u00a0 (6a,10a)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (other trade names are: HU-210 and HU-211);\n\u00a0\u00a0\u00a0 (11) Tetramethylcyclopropanoylindoles; meaning any compound containing a 3-tetramethylcyclopropanoylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,\u00a0 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the tetramethylcyclopropyl ring to any extent;\n\u00a0\u00a0\u00a0 (12)\u00a0 N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 APINACA, AKB48); \n\u00a0\u00a0\u00a0 (13)\u00a0 Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 PB-22; QUPIC);\n\u00a0\u00a0\u00a0 (14)\u00a0 Quinolin-8-yl 1-(5fluoropentyl)-1H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 5-fluoro-PB-22; 5F-PB-22);\n\u00a0\u00a0\u00a0 (15)\u00a0 N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 AB-FUBINACA);\n\u00a0\u00a0\u00a0 (16)\u00a0 N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 ADB-PINACA);\n\u00a0\u00a0\u00a0 (17)\u00a0 N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 AB-CHMINACA);\n\u00a0\u00a0\u00a0 (18)\u00a0 N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 AB-PINACA);\n\u00a0\u00a0\u00a0 (19)\u00a0 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 THJ-2201);\n\u00a0\u00a0\u00a0 (20)\u00a0 Methyl (1-(4-fluorobenzyl)-1 H-indazole-3-carbonyl)-L-valinate, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 FUB-AMB);\n\u00a0\u00a0\u00a0 (21)\u00a0 (S)-methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 5-fluoro-AMB, 5-fluoro-AMP);\n\u00a0\u00a0\u00a0 (22)\u00a0 N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 AKB48 N-(5-fluoropentyl) analog, 5F-AKB48, APINACA 5-fluoropentyl analog, 5F-APINACA);\n\u00a0\u00a0\u00a0 (23)\u00a0 N-adamantyl-1-fluoropentylindole-3-Carboxamide, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 STS-135, 5F-APICA; 5-fluoro-APICA);\n\u00a0\u00a0\u00a0 (24)\u00a0 Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-caboxylate, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 NM2201); and\n\u00a0\u00a0\u00a0 (25)\u00a0 N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, and geometric isomers, salts, and salts of isomers (Other names:\u00a0 MAB-CHMINACA and ADB-CHMINACA). [L 1972, c 10, pt of \u00a71; am L 1974, c 217, \u00a71; am L 1977, c 116, \u00a71; am L 1978, c 68, \u00a72; am L 1979, c 194, \u00a71; am L 1980, c 140, \u00a71 and c 232, \u00a716; am L 1984, c 166, \u00a71; am L 1985, c 150, \u00a71; am L 1986, c 214, \u00a7\u00a72, 3; am L 1988, c 59, \u00a71; am L 1990, c 138, \u00a73; am L 1993, c 8, \u00a71; am L 1995, c 122, \u00a71; am L 1997, c 356, \u00a71; am L 1999, c 252, \u00a72; am L 2000, c 98, \u00a71; am L 2001, c 203, \u00a72; am L 2003, c 151, \u00a7\u00a71, 2; am L 2008, c 119, \u00a73; am L 2010, c 123, \u00a71; am L 2011, c 73, \u00a71; am L 2012, c 29, \u00a71; am L 2013, c 48, \u00a71; am L 2014, c 54, \u00a71; am L 2015, c 195, \u00a71; am L 2016, c 218, \u00a7\u00a72, 3]\n\u00a0\nCase Notes\n\u00a0\n\u00a0 Proscription of distribution of lysergic acid \"diethylamine\" under this section (1974) cannot be extended by analogy under \u00a7701-104 to distribution of lysergic acid diethylamide.\u00a0 61 H. 74, 595 P.2d 288."
}